Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- MD BIOALPHA CO LTD
- Publication Date
- 2007-01-24
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to a composition for preventing and treating metabolic syndrome, which contains a tanshinone derivative as an effective component. More specifically, the present invention relates to a composition for the prevention and treatment of metabolic syndrome comprising, as an active ingredient, a tanshinone derivative exhibiting excellent activity in enhancing metabolic activity. Background of the invention
[0002] Metabolic syndrome refers to a syndrome including health risk factors such as hypertriglyceridemia, hypertension, glucose metabolism disorder, blood coagulation disorder, and obesity. Metabolic syndrome is not fatal, but it indicates a predisposition to serious diseases such as diabetes and ischemic cardiovascular disease, and has evolved into the most threatening disease of the modern population. Due to lack of understanding of the etiology of this syndrome, metabolic syndrome was once known by a variety of other...